nach oben

Diabetologia

Erschienen in:

01.03.2006 | Article

Downregulation of protein kinase B/Akt-1 mediates INS-1 insulinoma cell apoptosis induced by dominant-negative suppression of hepatocyte nuclear factor-1alpha function

verfasst von: H. Wobser, C. Bonner, J. J. Nolan, M. M. Byrne, J. H. M. Prehn

Erschienen in: Diabetologia | Ausgabe 3/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Inactivating mutations in Tcf1, which encodes the transcription factor hepatocyte nuclear factor (HNF)-1alpha, cause maturity-onset diabetes of the young-3. We have previously shown that a dominant-negative mutant (DN-HNF-1alpha) renders INS-1 insulinoma cells sensitive to the mitochondrial apoptosis pathway, but the underlying alterations in signal transduction remain unknown.

Materials and methods

Using a reverse tetracycline-dependent transactivator system, DN-HNF-1alpha-induced apoptosis was assessed by immunoblotting and caspase assays. Alterations in AKT1 kinase/protein kinase B (AKT1) survival signalling during DN-HNF-1alpha-induced apoptosis were investigated by phospho-specific immunodetection and transient transfection experiments.

Results

Induction of DN-HNF-1alpha caused significant changes in the activation-specific phosphorylation status of AKT1 that were preceded by a downregulation of Ins1 gene transcription. Phosphorylation of AKT1 at Ser473 was dramatically reduced after 36 to 48 h of DN-HNF-1alpha induction and coincided with maximal apoptosis activation. Overexpression of a constitutively active mutant of Akt1 rescued INS-1 cells from DN-HNF-1alpha-induced apoptosis, while ectopic expression of a dominant-negative mutant mimicked the effect of DN-HNF-1alpha on apoptosis activation. Pharmacological suppression of growth factor survival signalling through administration of the phosphatidylinositol-3 kinase (PI-3K) inhibitor wortmannin accelerated the induction of apoptosis by DN-HNF-1alpha.

Conclusions/interpretation

These data suggest that a decrease in PI-3K/AKT1 survival signalling mediates DN-HNF-1alpha-induced apoptosis in insulin-secreting cells.

Fajans SS, Bell G, Polonsky KS (2001) Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980CrossRefPubMed

Velho G, Froguel P (1998) Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young. Eur J Endocrinol 138:233–239CrossRefPubMed

Yamagata K, Oda N, Kaisaki PJ et al (1996) Mutations in the hepatocyte nuclear factor-1alpha gene in maturity onset diabetes at young age (MODY3). Nature 384:455–458CrossRefPubMed

Frayling TM, Evans JC, Bulman MP et al (2001) Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes 50 (Suppl 1):S94–S100PubMedCrossRef

Pontogloi M, Sreenan S, Michael R et al (1998) Defective insulin secretion in the hepatocyte nuclear factor-1alpha deficient mice. J Clin Invest 101:2215–2222PubMedCrossRef

Dukes ID, Sreenan S, Roe M et al (1998) Defective pancreatic beta cell glycolytic signaling in hepatocyte nuclear factor-1alpha deficient mice. J Biol Chem 273:24457–24464CrossRefPubMed

Shih DQ, Screenan S, Munoz KN et al (2001) Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50:2472–2480PubMedCrossRef

Shih DQ, Bussen M, Sehayek E et al (2001) Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Nat Genet 27:375–382CrossRefPubMed

Wang H, Maechler P, Hagenfeldt K et al (1998) Dominant-negative suppression of HNF1alpha function results in defective insulin gene transcription and impaired metabolism-secretion coupling in a pancreatic beta cell line. EMBO J 17:6701–6713CrossRefPubMed

10.

Wang H, Antinozzi P, Hagenfeldt K et al (2000) Molecular targets of a human HNF1alpha mutation responsible for pancreatic beta cell dysfunction. EMBO J 19:4257–4264CrossRefPubMed

11.

Love-Gregory LD, Wasson J, Ma J et al (2004) A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an Ashkenazi Jewish population. Diabetes 53:1134–1140PubMedCrossRef

12.

Silander K, Mohlke KL, Scott LJ et al (2004) Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 53:1141–1149PubMedCrossRef

13.

Jackson AE, Cassell PG, North BV et al (2004) Polymorphic variations in the neurogenic differentiation-1, neurogenin-3, and hepatocyte nuclear factor-1alpha genes contribute to glucose intolerance in a South Indian population. Diabetes 53:2122–2125PubMedCrossRef

14.

Clark A, Wells CA, Buley ID et al (1988) Islet amyloid, increased alpha-cells, reduced beta cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res 9:151–159PubMed

15.

Butler AE, Janson J, Bonner-Weir S et al (2003) Beta cell deficit and increased beta cell apoptosis in humans with type 2 diabetes. Diabetes 52:102–110PubMedCrossRef

16.

Pick A, Clark J, Kubstrup C et al (1998) Role of apoptosis in failure of beta cell mass compensation for insulin resistance and beta cell defects in the male Zucker diabetic fatty rat. Diabetes 47:358–364PubMedCrossRef

17.

Donath MY, Gross D, Cerasi E et al (1999) Hyperglycemia-induced beta cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744PubMedCrossRef

18.

Byrne MM, Sturis J, Menzel S et al (1996) Altered insulin secretory response to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503–1510PubMedCrossRef

19.

Hagenfeldt-Johansson KA, Herrera P, Wang H et al (2001) Beta-cell-targeted expression of a dominant negative hepatocyte nuclear factor-1alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology 142:5311–5320CrossRefPubMed

20.

Yamagata K, Nammo T, Moriwaki M et al (2002) Overexpression of dominant negative mutant hepatocyte nuclear factor-1alpha in pancreatic beta cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta cell proliferation, and diabetes. Diabetes 51:114–123PubMedCrossRef

21.

Yang Q, Yamagata K, Fukui K et al (2002) Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-I in INS-1 cells. Diabetes 51:1785–1792PubMedCrossRef

22.

Wobser H, Düssmann H, Kögel D et al (2002) Dominant negative suppression of HNF-1alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death. J Biol Chem 277:6413–6421CrossRefPubMed

23.

Andejelkovic M, Alessi DR, Meier R et al (1997) Role of translocation in the activation and function of protein kinase B. J Biol Chem 272:31515–31524CrossRefPubMed

24.

Stokoe D, Stephens LR, Copeland T et al (1997) Dual role of phosphatidylinositol-3,4,5-triphosphate in the activation of protein kinase B. Science 279:567–570CrossRef

25.

Alessi DR, Andjelkovic M, Caudwell B et al (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541–6551PubMed

26.

Alessi DR, James SR, Downes CP et al (1997) Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol 7:261–269CrossRefPubMed

27.

Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex. Science 307:1098–1101CrossRefPubMed

28.

Shin I, Yakes F, Rojo F (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27/kip1 at threonine 157 and modulation of its cellular localization. Nat Med 8:1145–1152CrossRefPubMed

29.

Datta SR, Dudek H, Tao X et al (1997) Akt phosphorylation of BAD couples survival signals to the intrinsic death machinery. Cell 91:231–241CrossRefPubMed

30.

Cardone MH, Roy N, Stennicke HR et al (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282:318–321CrossRef

31.

Nicosia A, Monaci P, Tomei L et al (1990) A myosin-like dimerization helix and an extra-large homeodomain are essential elements of the tripartite DNA binding structure of LFB1. Cell 6:1225–1236CrossRef

32.

Rehm M, Dussmann H, Janicke RU, Tavare JM, Kogel D, Prehn JH (2002) Single-cell fluorescence resonance energy transfer analysis demonstrates that caspase activation during apoptosis is a rapid process. Role of caspase-3. J Biol Chem 277:24506–24514CrossRefPubMed

33.

Leibiger IB, Leibiger B, Berggen PO (2002) Insulin feedback on pancreatic beta-cell function. FEBS Lett 532:1–6CrossRefPubMed

34.

Leibiger IB, Leibiger B, Berggren PO (1998) Exocytosis of insulin promotes insulin gene transcription via the insulin receptor/PI-3 kinase/p70 s6 kinase and CaM kinase pathways. Mol Cell 1:933–938CrossRefPubMed

35.

Navarro-Tableros V, Sanchez-Soto MC, Garcia S, Hiriart M (2004) Autocrine regulation of single pancreatic beta cell survival. Diabetes 53:2018–2023PubMedCrossRef

36.

Tuttle RL, Gill NS, William P (2001) Regulation of pancreatic beta cell growth and survival by the serine/threonine protein kinase Akt1/PKB. Nat Med 7:1133–1137CrossRefPubMed

37.

Chen WS, Xu P, Gottlob K (2001) Growth retardation and increased apoptosis in mice with homozygous disruption of akt1 gene. Genes Dev 15:2203–2208CrossRefPubMed

38.

Flynn P, Wong M, Zavar M et al (2000) Inhibition of PDK-1 activity causes a reduction in cell proliferation and survival. Curr Biol 10:1439–1442CrossRefPubMed

39.

Emens LA, Landers DW, Moss LG (1992) Hepatocyte nuclear factor 1 alpha is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc Natl Acad Sci USA 89:7300–7304PubMedCrossRef

40.

Kulik VP, Kavsan VM, van Schaik VM et al (1995) The promotor of the salmon insulin-like growth factor 1 gene is activated by hepatocyte nuclear factor 1alpha. J Biol Chem 270:1068–1073CrossRefPubMed

41.

Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty D (1999) Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286:2358–2361CrossRefPubMed

42.

Du K, Montminy M (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273:32377–32379CrossRefPubMed

43.

Chao DT, Korsmeyer S (1998) BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395–419CrossRefPubMed

44.

Brunet A, Bonni A, Zigmond MJ et al (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857–868CrossRefPubMed

45.

Dijkers PF, Medema RH, Lammers JK et al (2000) Expression of the proapoptotic Bcl-2 family member Bim is regulated by the Forkhead transcription factor FKHR-L1. Curr Biol 10:1201–1204CrossRefPubMed

46.

Kuwana Tchier-Hayes L, Chipuk JE et al (2005) BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17:525–535PubMedCrossRef

47.

Hui H, Nourparvar A, Zhao X, Perfetti R (2003) Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5’-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-dependent pathway. Endocrinology 144:1444–1455CrossRefPubMed

48.

Trumper A, Trumper K, Horsch D (2002) Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta (INS-1)-cells. J Endocrinol 174:233–246CrossRefPubMed

49.

Dai C, Li Y, Yang J, Liu Y (2003) Hepatocyte growth factor preserves beta cell mass and mitigates hyperglycemia in streptozotocin-induced diabetic mice. J Biol Chem 278:27080–27087CrossRefPubMed

50.

Widmann C, Gibson S, Johnson GL (1998) Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem 273:7141–7147CrossRefPubMed

Titel: Downregulation of protein kinase B/Akt-1 mediates INS-1 insulinoma cell apoptosis induced by dominant-negative suppression of hepatocyte nuclear factor-1alpha function
verfasst von: H. Wobser
C. Bonner
J. J. Nolan
M. M. Byrne
J. H. M. Prehn
Publikationsdatum: 01.03.2006
Verlag: Springer-Verlag
Erschienen in: Diabetologia / Ausgabe 3/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI: https://doi.org/10.1007/s00125-005-0119-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Aims/hypothesis

Materials and methods

Results

Conclusions/interpretation

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2006

Major quantitative trait locus on chromosome 2 for glucose tolerance in diabetic SMXA-5 mouse established from non-diabetic SM/J and A/J strains

Diabetes quantitative trait locus research: from physiology to genetics and back

Activin receptor-like kinase 7 induces apoptosis of pancreatic beta cells and beta cell lines

Evidence that oestrogen receptor-α plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver

Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice